Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David James

Showing results (641-650 of 763) with videos related to

Pageof 77
Sort By:
Neuro-Oncology|December 4, 2014
Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor αHaizhong Feng, Yanxin Li, Yuhua Yin, et al.
Cancer Research|January 14, 2010
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomasJoshua D Schiffman, J Graeme Hodgson, Scott R VandenBerg, et al.
Neuro-Oncology|March 20, 2024
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastomaShreya Budhiraja, Graysen McManus, Shivani Baisiwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Editor's Note: BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2016
BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Cancer Research Communications|November 16, 2022
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progressionMariafausta Fischietti, Frank Eckerdt, Ricardo E Perez, et al.
Journal of Neuro-Oncology|September 20, 2015
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Neuro-Oncology|January 14, 2009
Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenograftsJ Graeme Hodgson, Ru-Fang Yeh, Amrita Ray, et al.
Journal of Neuro-Oncology|January 20, 2016
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Pageof 77

Showing results (641-650 of 763) with videos related to

Sort By:
Pageof 77
Neuro-Oncology|December 4, 2014
Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor αHaizhong Feng, Yanxin Li, Yuhua Yin, et al.
Cancer Research|January 14, 2010
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomasJoshua D Schiffman, J Graeme Hodgson, Scott R VandenBerg, et al.
Neuro-Oncology|March 20, 2024
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastomaShreya Budhiraja, Graysen McManus, Shivani Baisiwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Editor's Note: BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2016
BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Cancer Research Communications|November 16, 2022
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progressionMariafausta Fischietti, Frank Eckerdt, Ricardo E Perez, et al.
Journal of Neuro-Oncology|September 20, 2015
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Neuro-Oncology|January 14, 2009
Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenograftsJ Graeme Hodgson, Ru-Fang Yeh, Amrita Ray, et al.
Journal of Neuro-Oncology|January 20, 2016
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Pageof 77